Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.70 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.70 |
| ▸ | DPP4 | P27487 | 1/20 | 0.48 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.48 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.48 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.44 |
| ▸ | ENPEP | Q07075 | 7/20 | 0.43 |
| ▸ | ANPEP | P15144 | 4/20 | 0.43 |
| ▸ | GRM8 | O00222 | 1/20 | 0.42 |
| ▸ | GRM6 | O15303 | 1/20 | 0.42 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.42 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.42 |
| ▸ | GSR | P00390 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.42 |
| ▸ | GRM5 | P41594 | 1/20 | 0.42 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.42 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.42 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL931787 | 1.00 | PTGS1 (0.70) | PTGS1GSTK1DPP4DPP8DPP9 | |
| Sulfurous Acid SCHEMBL15348261 | 0.94 | PTGS1 (0.64) | PTGS1GSTK1DPP4DPP8DPP9 | |
| SCHEMBL15333593 | 0.91 | PTGS1 (0.67) | PTGS1GSTK1DPP4DPP8DPP9 | |
| SCHEMBL209655 | 0.91 | PTGS1 (0.67) | PTGS1GSTK1DPP4DPP8DPP9 | |
| Glutathione SCHEMBL711491 | 0.91 | PTGS1 (0.88) | PTGS1GSTK1DPP4DPP8DPP9 | |
| SCHEMBL15348170 | 0.90 | PTGS1 (0.65) | PTGS1GSTK1DPP4DPP8DPP9 | |
| SCHEMBL173099 | 0.89 | PTGS1 (0.55) | PTGS1GSTK1DPP4DPP8DPP9 | |
| SCHEMBL29384215 | 0.89 | PTGS1 (0.55) | PTGS1GSTK1DPP4DPP8DPP9 | |
| SCHEMBL15348168 | 0.89 | PTGS1 (0.56) | PTGS1GSTK1DPP4DPP8DPP9 | |
| SCHEMBL22589611 | 0.89 | PTGS1 (0.60) | PTGS1GSTK1DPP4DPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 443 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118897023-B | Method for directly measuring alpha and gamma-glutamyl peptide in skeletal muscle by using LC-MS and isotope dilution assay | 中国农业科学院北京畜牧兽医研究所 | 2025-03-25 | — | — | CN | claimed |
| WO-2024170850-A1 | MEDIUM AND METHOD FOR THE GROWTH OF METHANOGENIC ARCHAEA | FONDATION MÉDITERRANÉE INFECTION (FR) | 2024-08-22 | — | — | WO | claimed |
| CN-118240007-A | Polypeptide and application thereof in preventing or repairing mucous membrane injury and promoting cornea injury recovery | 四川好医生攀西药业有限责任公司 | 2024-06-25 | — | — | CN | claimed |
| US-20230279342-A1 | METHOD FOR MEDIUM TREATMENT BEFORE INOCULATION | HOFFMANN-LA ROCHE INC. (US) | 2023-09-07 | — | — | US | claimed |
| EP-4136212-A1 | METHOD FOR MEDIUM TREATMENT BEFORE INOCULATION | Genentech, Inc. (US) | 2023-02-22 | — | — | EP | claimed |
| EP-3395372-B1 | GLUTATHIONE-BASED DRUG DELIVERY SYSTEM | ENHANX BIOPHARM INC (TW) | 2022-04-06 | — | — | EP | claimed |
| WO-2021209512-A1 | METHOD FOR MEDIUM TREATMENT BEFORE INOCULATION | GENENTECH, INC. (US) | 2021-10-21 | — | — | WO | claimed |
| EP-2721051-A1 | A METHOD FOR THE PRODUCTION OF HYDROLYZED ALLERGENS | Biotech Tools S.A. (BE) | 2014-04-23 | — | — | EP | claimed |
| CN-103582646-A | Antiviral agent | IVY PHARM LTD LIABILITY COMPANY | 2014-02-12 | — | — | CN | claimed |
| EP-2664614-A1 | PALLADIUM-COPPER CATALYSTS FOR THE HOMOGENEOUS SELECTIVE OXIDATION OF THIOL GROUPS | "Ivy Pharm" Limited Liability Company (RU) | 2013-11-20 | — | — | EP | claimed |
| WO-2008002678-A2 | STRUCTURAL-BASED INHIBITORS OF THE GLUTATHIONE BINDING SITE IN ALDOSE REDUCTASE, METHODS OF SCREENING THEREFOR AND METHODS OF USE | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2008-01-03 | — | — | WO | claimed |
| EP-1641488-A1 | EPITOPE COMPOSITION FOR SUBLINGUAL, BUCCAL OR ENTERIC ADMINISTRATION PREPARED BY HYDROLYSIS OF ANTIGENIC STRUCTURES WITH CHYMOTRYPSIN | BioTech Tools S.A. (BE) | 2006-04-05 | — | — | EP | claimed |
| WO-2004112833-A1 | EPITOPE COMPOSITION FOR SUBLINGUAL, BUCCAL OR ENTERIC ADMINISTRATION PREPARED BY HYDROLYSIS OF ANTIGENIC STRUCTURES WITH CHYMOTRYPSIN | BIOTECH TOOLS SA (BE) | 2004-12-29 | — | — | WO | claimed |
| CN-1161149-C | Cytokine and hemopoietic factor endogenous production enhancer and method of use thereof | 诺维罗斯治疗学公司 | 2004-08-11 | — | — | CN | claimed |
| US-6239111-B1 | DRUG FOR TREATING BRAIN DISEASES, ENABLES PREVENTION OR TREATMENT OF DEMENTIA AND SIMILAR DISEASES CAUSED BY DEGENERATION OR SLOUGHING OF NEURONS, AN ALLY SULFIDE, SULFOXIDE OR SULFONE | WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-29 | — | — | US | claimed |
| CN-1166320-A | Composite of zinc containing compound and glutamines | XIA XIAOLIN (CN) | 1997-12-03 | — | — | CN | claimed |
| US-5589277-A | INK JET PRINTING, AQUEOUS INKS, FAST DRYING | XEROX CORPORATION (US) | 1996-12-31 | — | — | US | claimed |
| EP-0604433-A4 | COMPOSITION AND METHOD FOR DISEASE TREATMENT. | LIFE SCIENCES TECH INC (US) | 1994-10-12 | — | — | EP | claimed |
| EP-0604433-A1 | COMPOSITION AND METHOD FOR DISEASE TREATMENT | LIFE SCIENCES' TECHNOLOGIES, INC. (US) | 1994-07-06 | — | — | EP | claimed |
| WO-1992021368-A1 | COMPOSITION AND METHOD FOR DISEASE TREATMENT | LIFE SCIENCES' TECHNOLOGIES, INC. (US) | 1992-12-10 | — | — | WO | claimed |